These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 781925)

  • 1. Letter: Steroids and cyclophosphamide dosage in renal allograft perfusion.
    Woods JE; Zincke H
    Transplantation; 1976 Mar; 21(3):260. PubMed ID: 781925
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological donor pretreatment in combination with pulsatile preservation in cadaveric renal transplantation.
    Zincke H; Woods JE; Khan AU; Holley KE; Leary FJ
    Transplantation; 1978 Oct; 26(4):207-11. PubMed ID: 360522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of high dose steroid and cyclophosphamide on perfused canine renal homografts.
    Tremann JA; Haines JG; Bleifuss JH; Agodoa LC; Marchioro TL
    Transplantation; 1975 Jun; 19(6):520-2. PubMed ID: 1094642
    [No Abstract]   [Full Text] [Related]  

  • 4. Attempted immunological alteration of canine renal allograft donors.
    Zincke H; Woods JE
    Transplantation; 1974 Dec; 18(6):480-6. PubMed ID: 4612885
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor pretreatment on perfused cadaver kidneys: experimental observations.
    Sy G; Taiyebb S; Toledo-Pereyra LH
    Am Surg; 1981 Jul; 47(7):307-8. PubMed ID: 7020513
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts.
    Zincke H; Woods JE; Holley KE
    Urology; 1977 Oct; 10(4):301-4. PubMed ID: 335605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-day perfusion of canine kidneys: a postulated effect of steroids.
    Woods JE; Fleisher GA; Hirsche BL
    Transplant Proc; 1974 Sep; 6(3):255-60. PubMed ID: 4153357
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of donor pretreatment prolongs canine renal allograft survival.
    Dienst SG; MacDonald R; Toledo-Pereyra LH; Fox B
    Transplant Proc; 1979 Jun; 11(2):1465-6. PubMed ID: 382541
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefits of methylprednisolone in the isolated perfused organ.
    Starling JR; Rudolf LE; Ferguson W; Wangensteen SL
    Ann Surg; 1973 May; 177(5):566-71. PubMed ID: 4574226
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction of acute tubular necrosis (ATN) by furosemide and steroids in cadaveric kidney recovery.
    McCabe R; Stevens LE; Subramamian A; Lattes C; Hashim GM
    Am J Surg; 1975 Mar; 129(3):246-8. PubMed ID: 1091177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pharmacological doses of methylprednisolone on preservation of renal function.
    Rashid HA; Panner BJ; Linke CA
    J Surg Res; 1975 Jan; 18(1):21-8. PubMed ID: 1117712
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of methylprednisolone, glucagon, and allopurinol in the protection of pancreaticoduodenal allografts perfused for twenty-four hours.
    Tersigni R; Toledo-Pereyra LH; Najarian JS
    Surgery; 1975 Nov; 78(5):599-607. PubMed ID: 1103338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

  • 14. Organ preservation.
    Lancet; 1973 Sep; 2(7831):715-6. PubMed ID: 4125799
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal management of warm ischemic kidneys prior to hypothermic preservation.
    Toledo-Pereyra LH; Moberg AW; Najarian JS
    Transplant Proc; 1974 Sep; 6(3):279-82. PubMed ID: 4606875
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation.
    Zincke H; Woods JE; Roses J; Kimbler RW
    Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of donor pretreatment and low-dose immunosuppression on the 24-hour preserved canine renal allograft.
    Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Fitzpatrick HF
    Transplant Proc; 1979 Sep; 11(3):1673-5. PubMed ID: 388773
    [No Abstract]   [Full Text] [Related]  

  • 18. Perfusates for preservation of kidneys, livers and hearts.
    Humphries AL; Liu WP
    Ann Anesthesiol Fr; 1974; 15 SPEC NO 3():183-99. PubMed ID: 4617525
    [No Abstract]   [Full Text] [Related]  

  • 19. Attempted antigenic alteration of canine kidneys by 24- or 48-hr perfusion with immunosuppressive agents.
    Woods JE; Cooperman AM; Holley KE
    Transplantation; 1972 Mar; 13(3):336. PubMed ID: 4553735
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolongation of canine allograft survival with donor pretreatment.
    Brom HL; van Breda Vriesman PJ; Terpstra JL
    Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.